Global Recombinant FSH Injections Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Recombinant FSH Injections market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Follicle Stimulating Hormone (FSH) injections are pharmaceutical preparations containing the hormone FSH, a crucial component in the regulation of reproductive processes. FSH is produced by the pituitary gland and plays a key role in the stimulation of ovarian follicles in females and sperm production in males. FSH injections are commonly used in assisted reproductive technologies, such as in vitro fertilization (IVF), to enhance the development and maturation of multiple follicles in the ovaries. In fertility treatments, these injections help regulate and stimulate the ovaries to produce more eggs, increasing the chances of successful fertilization and pregnancy.
Human follicle stimulating hormone (FSH) includes urinary human follicle stimulating hormone (uFSH) and recombinant FSH (rFSH). According to expert consensus, recombinant follicle-stimulating hormone is available in two dosage forms: powder injection and water injection.
The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.
The Global Info Research report includes an overview of the development of the Recombinant FSH Injections industry chain, the market status of IVF and Embryo Transfer (Powder, Liquid), Infertility Treatment (Powder, Liquid), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Recombinant FSH Injections.
Regionally, the report analyzes the Recombinant FSH Injections markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Recombinant FSH Injections market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Recombinant FSH Injections market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Recombinant FSH Injections industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Powder, Liquid).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Recombinant FSH Injections market.
Regional Analysis: The report involves examining the Recombinant FSH Injections market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Recombinant FSH Injections market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Recombinant FSH Injections:
Company Analysis: Report covers individual Recombinant FSH Injections manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Recombinant FSH Injections This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (IVF and Embryo Transfer, Infertility Treatment).
Technology Analysis: Report covers specific technologies relevant to Recombinant FSH Injections. It assesses the current state, advancements, and potential future developments in Recombinant FSH Injections areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Recombinant FSH Injections market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Recombinant FSH Injections market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Recombinant FSH Injections product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant FSH Injections, with price, sales, revenue and global market share of Recombinant FSH Injections from 2019 to 2024.
Chapter 3, the Recombinant FSH Injections competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant FSH Injections breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Recombinant FSH Injections market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant FSH Injections.
Chapter 14 and 15, to describe Recombinant FSH Injections sales channel, distributors, customers, research findings and conclusion.
Follicle Stimulating Hormone (FSH) injections are pharmaceutical preparations containing the hormone FSH, a crucial component in the regulation of reproductive processes. FSH is produced by the pituitary gland and plays a key role in the stimulation of ovarian follicles in females and sperm production in males. FSH injections are commonly used in assisted reproductive technologies, such as in vitro fertilization (IVF), to enhance the development and maturation of multiple follicles in the ovaries. In fertility treatments, these injections help regulate and stimulate the ovaries to produce more eggs, increasing the chances of successful fertilization and pregnancy.
Human follicle stimulating hormone (FSH) includes urinary human follicle stimulating hormone (uFSH) and recombinant FSH (rFSH). According to expert consensus, recombinant follicle-stimulating hormone is available in two dosage forms: powder injection and water injection.
The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.
The Global Info Research report includes an overview of the development of the Recombinant FSH Injections industry chain, the market status of IVF and Embryo Transfer (Powder, Liquid), Infertility Treatment (Powder, Liquid), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Recombinant FSH Injections.
Regionally, the report analyzes the Recombinant FSH Injections markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Recombinant FSH Injections market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Recombinant FSH Injections market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Recombinant FSH Injections industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Powder, Liquid).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Recombinant FSH Injections market.
Regional Analysis: The report involves examining the Recombinant FSH Injections market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Recombinant FSH Injections market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Recombinant FSH Injections:
Company Analysis: Report covers individual Recombinant FSH Injections manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Recombinant FSH Injections This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (IVF and Embryo Transfer, Infertility Treatment).
Technology Analysis: Report covers specific technologies relevant to Recombinant FSH Injections. It assesses the current state, advancements, and potential future developments in Recombinant FSH Injections areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Recombinant FSH Injections market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Recombinant FSH Injections market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Powder
- Liquid
- IVF and Embryo Transfer
- Infertility Treatment
- Gonal-F (Merck)
- Follistim (Organon)
- Bravelle (Ferring)
- Menopur (Ferring)
- Fostimon (IBSA)
- Puregon (Organon)
- BEMFOLA (Gedeon Richter)
- Follitrope (LG Chem)
- GenSci
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Recombinant FSH Injections product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant FSH Injections, with price, sales, revenue and global market share of Recombinant FSH Injections from 2019 to 2024.
Chapter 3, the Recombinant FSH Injections competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant FSH Injections breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Recombinant FSH Injections market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant FSH Injections.
Chapter 14 and 15, to describe Recombinant FSH Injections sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Recombinant FSH Injections
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Recombinant FSH Injections Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Powder
1.3.3 Liquid
1.4 Market Analysis by Application
1.4.1 Overview: Global Recombinant FSH Injections Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 IVF and Embryo Transfer
1.4.3 Infertility Treatment
1.5 Global Recombinant FSH Injections Market Size & Forecast
1.5.1 Global Recombinant FSH Injections Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Recombinant FSH Injections Sales Quantity (2019-2030)
1.5.3 Global Recombinant FSH Injections Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Gonal-F (Merck)
2.1.1 Gonal-F (Merck) Details
2.1.2 Gonal-F (Merck) Major Business
2.1.3 Gonal-F (Merck) Recombinant FSH Injections Product and Services
2.1.4 Gonal-F (Merck) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Gonal-F (Merck) Recent Developments/Updates
2.2 Follistim (Organon)
2.2.1 Follistim (Organon) Details
2.2.2 Follistim (Organon) Major Business
2.2.3 Follistim (Organon) Recombinant FSH Injections Product and Services
2.2.4 Follistim (Organon) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Follistim (Organon) Recent Developments/Updates
2.3 Bravelle (Ferring)
2.3.1 Bravelle (Ferring) Details
2.3.2 Bravelle (Ferring) Major Business
2.3.3 Bravelle (Ferring) Recombinant FSH Injections Product and Services
2.3.4 Bravelle (Ferring) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bravelle (Ferring) Recent Developments/Updates
2.4 Menopur (Ferring)
2.4.1 Menopur (Ferring) Details
2.4.2 Menopur (Ferring) Major Business
2.4.3 Menopur (Ferring) Recombinant FSH Injections Product and Services
2.4.4 Menopur (Ferring) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Menopur (Ferring) Recent Developments/Updates
2.5 Fostimon (IBSA)
2.5.1 Fostimon (IBSA) Details
2.5.2 Fostimon (IBSA) Major Business
2.5.3 Fostimon (IBSA) Recombinant FSH Injections Product and Services
2.5.4 Fostimon (IBSA) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Fostimon (IBSA) Recent Developments/Updates
2.6 Puregon (Organon)
2.6.1 Puregon (Organon) Details
2.6.2 Puregon (Organon) Major Business
2.6.3 Puregon (Organon) Recombinant FSH Injections Product and Services
2.6.4 Puregon (Organon) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Puregon (Organon) Recent Developments/Updates
2.7 BEMFOLA (Gedeon Richter)
2.7.1 BEMFOLA (Gedeon Richter) Details
2.7.2 BEMFOLA (Gedeon Richter) Major Business
2.7.3 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product and Services
2.7.4 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 BEMFOLA (Gedeon Richter) Recent Developments/Updates
2.8 Follitrope (LG Chem)
2.8.1 Follitrope (LG Chem) Details
2.8.2 Follitrope (LG Chem) Major Business
2.8.3 Follitrope (LG Chem) Recombinant FSH Injections Product and Services
2.8.4 Follitrope (LG Chem) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Follitrope (LG Chem) Recent Developments/Updates
2.9 GenSci
2.9.1 GenSci Details
2.9.2 GenSci Major Business
2.9.3 GenSci Recombinant FSH Injections Product and Services
2.9.4 GenSci Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 GenSci Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RECOMBINANT FSH INJECTIONS BY MANUFACTURER
3.1 Global Recombinant FSH Injections Sales Quantity by Manufacturer (2019-2024)
3.2 Global Recombinant FSH Injections Revenue by Manufacturer (2019-2024)
3.3 Global Recombinant FSH Injections Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Recombinant FSH Injections by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Recombinant FSH Injections Manufacturer Market Share in 2023
3.4.2 Top 6 Recombinant FSH Injections Manufacturer Market Share in 2023
3.5 Recombinant FSH Injections Market: Overall Company Footprint Analysis
3.5.1 Recombinant FSH Injections Market: Region Footprint
3.5.2 Recombinant FSH Injections Market: Company Product Type Footprint
3.5.3 Recombinant FSH Injections Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Recombinant FSH Injections Market Size by Region
4.1.1 Global Recombinant FSH Injections Sales Quantity by Region (2019-2030)
4.1.2 Global Recombinant FSH Injections Consumption Value by Region (2019-2030)
4.1.3 Global Recombinant FSH Injections Average Price by Region (2019-2030)
4.2 North America Recombinant FSH Injections Consumption Value (2019-2030)
4.3 Europe Recombinant FSH Injections Consumption Value (2019-2030)
4.4 Asia-Pacific Recombinant FSH Injections Consumption Value (2019-2030)
4.5 South America Recombinant FSH Injections Consumption Value (2019-2030)
4.6 Middle East and Africa Recombinant FSH Injections Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Recombinant FSH Injections Sales Quantity by Type (2019-2030)
5.2 Global Recombinant FSH Injections Consumption Value by Type (2019-2030)
5.3 Global Recombinant FSH Injections Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Recombinant FSH Injections Sales Quantity by Application (2019-2030)
6.2 Global Recombinant FSH Injections Consumption Value by Application (2019-2030)
6.3 Global Recombinant FSH Injections Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Recombinant FSH Injections Sales Quantity by Type (2019-2030)
7.2 North America Recombinant FSH Injections Sales Quantity by Application (2019-2030)
7.3 North America Recombinant FSH Injections Market Size by Country
7.3.1 North America Recombinant FSH Injections Sales Quantity by Country (2019-2030)
7.3.2 North America Recombinant FSH Injections Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Recombinant FSH Injections Sales Quantity by Type (2019-2030)
8.2 Europe Recombinant FSH Injections Sales Quantity by Application (2019-2030)
8.3 Europe Recombinant FSH Injections Market Size by Country
8.3.1 Europe Recombinant FSH Injections Sales Quantity by Country (2019-2030)
8.3.2 Europe Recombinant FSH Injections Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Recombinant FSH Injections Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Recombinant FSH Injections Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Recombinant FSH Injections Market Size by Region
9.3.1 Asia-Pacific Recombinant FSH Injections Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Recombinant FSH Injections Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Recombinant FSH Injections Sales Quantity by Type (2019-2030)
10.2 South America Recombinant FSH Injections Sales Quantity by Application (2019-2030)
10.3 South America Recombinant FSH Injections Market Size by Country
10.3.1 South America Recombinant FSH Injections Sales Quantity by Country (2019-2030)
10.3.2 South America Recombinant FSH Injections Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Recombinant FSH Injections Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Recombinant FSH Injections Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Recombinant FSH Injections Market Size by Country
11.3.1 Middle East & Africa Recombinant FSH Injections Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Recombinant FSH Injections Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Recombinant FSH Injections Market Drivers
12.2 Recombinant FSH Injections Market Restraints
12.3 Recombinant FSH Injections Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Recombinant FSH Injections and Key Manufacturers
13.2 Manufacturing Costs Percentage of Recombinant FSH Injections
13.3 Recombinant FSH Injections Production Process
13.4 Recombinant FSH Injections Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Recombinant FSH Injections Typical Distributors
14.3 Recombinant FSH Injections Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Recombinant FSH Injections
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Recombinant FSH Injections Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Powder
1.3.3 Liquid
1.4 Market Analysis by Application
1.4.1 Overview: Global Recombinant FSH Injections Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 IVF and Embryo Transfer
1.4.3 Infertility Treatment
1.5 Global Recombinant FSH Injections Market Size & Forecast
1.5.1 Global Recombinant FSH Injections Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Recombinant FSH Injections Sales Quantity (2019-2030)
1.5.3 Global Recombinant FSH Injections Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Gonal-F (Merck)
2.1.1 Gonal-F (Merck) Details
2.1.2 Gonal-F (Merck) Major Business
2.1.3 Gonal-F (Merck) Recombinant FSH Injections Product and Services
2.1.4 Gonal-F (Merck) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Gonal-F (Merck) Recent Developments/Updates
2.2 Follistim (Organon)
2.2.1 Follistim (Organon) Details
2.2.2 Follistim (Organon) Major Business
2.2.3 Follistim (Organon) Recombinant FSH Injections Product and Services
2.2.4 Follistim (Organon) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Follistim (Organon) Recent Developments/Updates
2.3 Bravelle (Ferring)
2.3.1 Bravelle (Ferring) Details
2.3.2 Bravelle (Ferring) Major Business
2.3.3 Bravelle (Ferring) Recombinant FSH Injections Product and Services
2.3.4 Bravelle (Ferring) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bravelle (Ferring) Recent Developments/Updates
2.4 Menopur (Ferring)
2.4.1 Menopur (Ferring) Details
2.4.2 Menopur (Ferring) Major Business
2.4.3 Menopur (Ferring) Recombinant FSH Injections Product and Services
2.4.4 Menopur (Ferring) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Menopur (Ferring) Recent Developments/Updates
2.5 Fostimon (IBSA)
2.5.1 Fostimon (IBSA) Details
2.5.2 Fostimon (IBSA) Major Business
2.5.3 Fostimon (IBSA) Recombinant FSH Injections Product and Services
2.5.4 Fostimon (IBSA) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Fostimon (IBSA) Recent Developments/Updates
2.6 Puregon (Organon)
2.6.1 Puregon (Organon) Details
2.6.2 Puregon (Organon) Major Business
2.6.3 Puregon (Organon) Recombinant FSH Injections Product and Services
2.6.4 Puregon (Organon) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Puregon (Organon) Recent Developments/Updates
2.7 BEMFOLA (Gedeon Richter)
2.7.1 BEMFOLA (Gedeon Richter) Details
2.7.2 BEMFOLA (Gedeon Richter) Major Business
2.7.3 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product and Services
2.7.4 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 BEMFOLA (Gedeon Richter) Recent Developments/Updates
2.8 Follitrope (LG Chem)
2.8.1 Follitrope (LG Chem) Details
2.8.2 Follitrope (LG Chem) Major Business
2.8.3 Follitrope (LG Chem) Recombinant FSH Injections Product and Services
2.8.4 Follitrope (LG Chem) Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Follitrope (LG Chem) Recent Developments/Updates
2.9 GenSci
2.9.1 GenSci Details
2.9.2 GenSci Major Business
2.9.3 GenSci Recombinant FSH Injections Product and Services
2.9.4 GenSci Recombinant FSH Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 GenSci Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: RECOMBINANT FSH INJECTIONS BY MANUFACTURER
3.1 Global Recombinant FSH Injections Sales Quantity by Manufacturer (2019-2024)
3.2 Global Recombinant FSH Injections Revenue by Manufacturer (2019-2024)
3.3 Global Recombinant FSH Injections Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Recombinant FSH Injections by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Recombinant FSH Injections Manufacturer Market Share in 2023
3.4.2 Top 6 Recombinant FSH Injections Manufacturer Market Share in 2023
3.5 Recombinant FSH Injections Market: Overall Company Footprint Analysis
3.5.1 Recombinant FSH Injections Market: Region Footprint
3.5.2 Recombinant FSH Injections Market: Company Product Type Footprint
3.5.3 Recombinant FSH Injections Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Recombinant FSH Injections Market Size by Region
4.1.1 Global Recombinant FSH Injections Sales Quantity by Region (2019-2030)
4.1.2 Global Recombinant FSH Injections Consumption Value by Region (2019-2030)
4.1.3 Global Recombinant FSH Injections Average Price by Region (2019-2030)
4.2 North America Recombinant FSH Injections Consumption Value (2019-2030)
4.3 Europe Recombinant FSH Injections Consumption Value (2019-2030)
4.4 Asia-Pacific Recombinant FSH Injections Consumption Value (2019-2030)
4.5 South America Recombinant FSH Injections Consumption Value (2019-2030)
4.6 Middle East and Africa Recombinant FSH Injections Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Recombinant FSH Injections Sales Quantity by Type (2019-2030)
5.2 Global Recombinant FSH Injections Consumption Value by Type (2019-2030)
5.3 Global Recombinant FSH Injections Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Recombinant FSH Injections Sales Quantity by Application (2019-2030)
6.2 Global Recombinant FSH Injections Consumption Value by Application (2019-2030)
6.3 Global Recombinant FSH Injections Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Recombinant FSH Injections Sales Quantity by Type (2019-2030)
7.2 North America Recombinant FSH Injections Sales Quantity by Application (2019-2030)
7.3 North America Recombinant FSH Injections Market Size by Country
7.3.1 North America Recombinant FSH Injections Sales Quantity by Country (2019-2030)
7.3.2 North America Recombinant FSH Injections Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Recombinant FSH Injections Sales Quantity by Type (2019-2030)
8.2 Europe Recombinant FSH Injections Sales Quantity by Application (2019-2030)
8.3 Europe Recombinant FSH Injections Market Size by Country
8.3.1 Europe Recombinant FSH Injections Sales Quantity by Country (2019-2030)
8.3.2 Europe Recombinant FSH Injections Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Recombinant FSH Injections Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Recombinant FSH Injections Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Recombinant FSH Injections Market Size by Region
9.3.1 Asia-Pacific Recombinant FSH Injections Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Recombinant FSH Injections Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Recombinant FSH Injections Sales Quantity by Type (2019-2030)
10.2 South America Recombinant FSH Injections Sales Quantity by Application (2019-2030)
10.3 South America Recombinant FSH Injections Market Size by Country
10.3.1 South America Recombinant FSH Injections Sales Quantity by Country (2019-2030)
10.3.2 South America Recombinant FSH Injections Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Recombinant FSH Injections Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Recombinant FSH Injections Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Recombinant FSH Injections Market Size by Country
11.3.1 Middle East & Africa Recombinant FSH Injections Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Recombinant FSH Injections Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Recombinant FSH Injections Market Drivers
12.2 Recombinant FSH Injections Market Restraints
12.3 Recombinant FSH Injections Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Recombinant FSH Injections and Key Manufacturers
13.2 Manufacturing Costs Percentage of Recombinant FSH Injections
13.3 Recombinant FSH Injections Production Process
13.4 Recombinant FSH Injections Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Recombinant FSH Injections Typical Distributors
14.3 Recombinant FSH Injections Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Recombinant FSH Injections Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Recombinant FSH Injections Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Gonal-F (Merck) Basic Information, Manufacturing Base and Competitors
Table 4. Gonal-F (Merck) Major Business
Table 5. Gonal-F (Merck) Recombinant FSH Injections Product and Services
Table 6. Gonal-F (Merck) Recombinant FSH Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Gonal-F (Merck) Recent Developments/Updates
Table 8. Follistim (Organon) Basic Information, Manufacturing Base and Competitors
Table 9. Follistim (Organon) Major Business
Table 10. Follistim (Organon) Recombinant FSH Injections Product and Services
Table 11. Follistim (Organon) Recombinant FSH Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Follistim (Organon) Recent Developments/Updates
Table 13. Bravelle (Ferring) Basic Information, Manufacturing Base and Competitors
Table 14. Bravelle (Ferring) Major Business
Table 15. Bravelle (Ferring) Recombinant FSH Injections Product and Services
Table 16. Bravelle (Ferring) Recombinant FSH Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Bravelle (Ferring) Recent Developments/Updates
Table 18. Menopur (Ferring) Basic Information, Manufacturing Base and Competitors
Table 19. Menopur (Ferring) Major Business
Table 20. Menopur (Ferring) Recombinant FSH Injections Product and Services
Table 21. Menopur (Ferring) Recombinant FSH Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Menopur (Ferring) Recent Developments/Updates
Table 23. Fostimon (IBSA) Basic Information, Manufacturing Base and Competitors
Table 24. Fostimon (IBSA) Major Business
Table 25. Fostimon (IBSA) Recombinant FSH Injections Product and Services
Table 26. Fostimon (IBSA) Recombinant FSH Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Fostimon (IBSA) Recent Developments/Updates
Table 28. Puregon (Organon) Basic Information, Manufacturing Base and Competitors
Table 29. Puregon (Organon) Major Business
Table 30. Puregon (Organon) Recombinant FSH Injections Product and Services
Table 31. Puregon (Organon) Recombinant FSH Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Puregon (Organon) Recent Developments/Updates
Table 33. BEMFOLA (Gedeon Richter) Basic Information, Manufacturing Base and Competitors
Table 34. BEMFOLA (Gedeon Richter) Major Business
Table 35. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product and Services
Table 36. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. BEMFOLA (Gedeon Richter) Recent Developments/Updates
Table 38. Follitrope (LG Chem) Basic Information, Manufacturing Base and Competitors
Table 39. Follitrope (LG Chem) Major Business
Table 40. Follitrope (LG Chem) Recombinant FSH Injections Product and Services
Table 41. Follitrope (LG Chem) Recombinant FSH Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Follitrope (LG Chem) Recent Developments/Updates
Table 43. GenSci Basic Information, Manufacturing Base and Competitors
Table 44. GenSci Major Business
Table 45. GenSci Recombinant FSH Injections Product and Services
Table 46. GenSci Recombinant FSH Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. GenSci Recent Developments/Updates
Table 48. Global Recombinant FSH Injections Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 49. Global Recombinant FSH Injections Revenue by Manufacturer (2019-2024) & (USD Million)
Table 50. Global Recombinant FSH Injections Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 51. Market Position of Manufacturers in Recombinant FSH Injections, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 52. Head Office and Recombinant FSH Injections Production Site of Key Manufacturer
Table 53. Recombinant FSH Injections Market: Company Product Type Footprint
Table 54. Recombinant FSH Injections Market: Company Product Application Footprint
Table 55. Recombinant FSH Injections New Market Entrants and Barriers to Market Entry
Table 56. Recombinant FSH Injections Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Recombinant FSH Injections Sales Quantity by Region (2019-2024) & (K Units)
Table 58. Global Recombinant FSH Injections Sales Quantity by Region (2025-2030) & (K Units)
Table 59. Global Recombinant FSH Injections Consumption Value by Region (2019-2024) & (USD Million)
Table 60. Global Recombinant FSH Injections Consumption Value by Region (2025-2030) & (USD Million)
Table 61. Global Recombinant FSH Injections Average Price by Region (2019-2024) & (US$/Unit)
Table 62. Global Recombinant FSH Injections Average Price by Region (2025-2030) & (US$/Unit)
Table 63. Global Recombinant FSH Injections Sales Quantity by Type (2019-2024) & (K Units)
Table 64. Global Recombinant FSH Injections Sales Quantity by Type (2025-2030) & (K Units)
Table 65. Global Recombinant FSH Injections Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Global Recombinant FSH Injections Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Global Recombinant FSH Injections Average Price by Type (2019-2024) & (US$/Unit)
Table 68. Global Recombinant FSH Injections Average Price by Type (2025-2030) & (US$/Unit)
Table 69. Global Recombinant FSH Injections Sales Quantity by Application (2019-2024) & (K Units)
Table 70. Global Recombinant FSH Injections Sales Quantity by Application (2025-2030) & (K Units)
Table 71. Global Recombinant FSH Injections Consumption Value by Application (2019-2024) & (USD Million)
Table 72. Global Recombinant FSH Injections Consumption Value by Application (2025-2030) & (USD Million)
Table 73. Global Recombinant FSH Injections Average Price by Application (2019-2024) & (US$/Unit)
Table 74. Global Recombinant FSH Injections Average Price by Application (2025-2030) & (US$/Unit)
Table 75. North America Recombinant FSH Injections Sales Quantity by Type (2019-2024) & (K Units)
Table 76. North America Recombinant FSH Injections Sales Quantity by Type (2025-2030) & (K Units)
Table 77. North America Recombinant FSH Injections Sales Quantity by Application (2019-2024) & (K Units)
Table 78. North America Recombinant FSH Injections Sales Quantity by Application (2025-2030) & (K Units)
Table 79. North America Recombinant FSH Injections Sales Quantity by Country (2019-2024) & (K Units)
Table 80. North America Recombinant FSH Injections Sales Quantity by Country (2025-2030) & (K Units)
Table 81. North America Recombinant FSH Injections Consumption Value by Country (2019-2024) & (USD Million)
Table 82. North America Recombinant FSH Injections Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Europe Recombinant FSH Injections Sales Quantity by Type (2019-2024) & (K Units)
Table 84. Europe Recombinant FSH Injections Sales Quantity by Type (2025-2030) & (K Units)
Table 85. Europe Recombinant FSH Injections Sales Quantity by Application (2019-2024) & (K Units)
Table 86. Europe Recombinant FSH Injections Sales Quantity by Application (2025-2030) & (K Units)
Table 87. Europe Recombinant FSH Injections Sales Quantity by Country (2019-2024) & (K Units)
Table 88. Europe Recombinant FSH Injections Sales Quantity by Country (2025-2030) & (K Units)
Table 89. Europe Recombinant FSH Injections Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Recombinant FSH Injections Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Recombinant FSH Injections Sales Quantity by Type (2019-2024) & (K Units)
Table 92. Asia-Pacific Recombinant FSH Injections Sales Quantity by Type (2025-2030) & (K Units)
Table 93. Asia-Pacific Recombinant FSH Injections Sales Quantity by Application (2019-2024) & (K Units)
Table 94. Asia-Pacific Recombinant FSH Injections Sales Quantity by Application (2025-2030) & (K Units)
Table 95. Asia-Pacific Recombinant FSH Injections Sales Quantity by Region (2019-2024) & (K Units)
Table 96. Asia-Pacific Recombinant FSH Injections Sales Quantity by Region (2025-2030) & (K Units)
Table 97. Asia-Pacific Recombinant FSH Injections Consumption Value by Region (2019-2024) & (USD Million)
Table 98. Asia-Pacific Recombinant FSH Injections Consumption Value by Region (2025-2030) & (USD Million)
Table 99. South America Recombinant FSH Injections Sales Quantity by Type (2019-2024) & (K Units)
Table 100. South America Recombinant FSH Injections Sales Quantity by Type (2025-2030) & (K Units)
Table 101. South America Recombinant FSH Injections Sales Quantity by Application (2019-2024) & (K Units)
Table 102. South America Recombinant FSH Injections Sales Quantity by Application (2025-2030) & (K Units)
Table 103. South America Recombinant FSH Injections Sales Quantity by Country (2019-2024) & (K Units)
Table 104. South America Recombinant FSH Injections Sales Quantity by Country (2025-2030) & (K Units)
Table 105. South America Recombinant FSH Injections Consumption Value by Country (2019-2024) & (USD Million)
Table 106. South America Recombinant FSH Injections Consumption Value by Country (2025-2030) & (USD Million)
Table 107. Middle East & Africa Recombinant FSH Injections Sales Quantity by Type (2019-2024) & (K Units)
Table 108. Middle East & Africa Recombinant FSH Injections Sales Quantity by Type (2025-2030) & (K Units)
Table 109. Middle East & Africa Recombinant FSH Injections Sales Quantity by Application (2019-2024) & (K Units)
Table 110. Middle East & Africa Recombinant FSH Injections Sales Quantity by Application (2025-2030) & (K Units)
Table 111. Middle East & Africa Recombinant FSH Injections Sales Quantity by Region (2019-2024) & (K Units)
Table 112. Middle East & Africa Recombinant FSH Injections Sales Quantity by Region (2025-2030) & (K Units)
Table 113. Middle East & Africa Recombinant FSH Injections Consumption Value by Region (2019-2024) & (USD Million)
Table 114. Middle East & Africa Recombinant FSH Injections Consumption Value by Region (2025-2030) & (USD Million)
Table 115. Recombinant FSH Injections Raw Material
Table 116. Key Manufacturers of Recombinant FSH Injections Raw Materials
Table 117. Recombinant FSH Injections Typical Distributors
Table 118. Recombinant FSH Injections Typical Customers
LIST OF FIGURE
s
Figure 1. Recombinant FSH Injections Picture
Figure 2. Global Recombinant FSH Injections Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Recombinant FSH Injections Consumption Value Market Share by Type in 2023
Figure 4. Powder Examples
Figure 5. Liquid Examples
Figure 6. Global Recombinant FSH Injections Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Recombinant FSH Injections Consumption Value Market Share by Application in 2023
Figure 8. IVF and Embryo Transfer Examples
Figure 9. Infertility Treatment Examples
Figure 10. Global Recombinant FSH Injections Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Recombinant FSH Injections Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Recombinant FSH Injections Sales Quantity (2019-2030) & (K Units)
Figure 13. Global Recombinant FSH Injections Average Price (2019-2030) & (US$/Unit)
Figure 14. Global Recombinant FSH Injections Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Recombinant FSH Injections Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Recombinant FSH Injections by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Recombinant FSH Injections Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Recombinant FSH Injections Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Recombinant FSH Injections Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Recombinant FSH Injections Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Recombinant FSH Injections Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Recombinant FSH Injections Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Recombinant FSH Injections Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Recombinant FSH Injections Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Recombinant FSH Injections Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Recombinant FSH Injections Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Recombinant FSH Injections Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Recombinant FSH Injections Average Price by Type (2019-2030) & (US$/Unit)
Figure 29. Global Recombinant FSH Injections Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Recombinant FSH Injections Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Recombinant FSH Injections Average Price by Application (2019-2030) & (US$/Unit)
Figure 32. North America Recombinant FSH Injections Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Recombinant FSH Injections Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Recombinant FSH Injections Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Recombinant FSH Injections Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Recombinant FSH Injections Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Recombinant FSH Injections Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Recombinant FSH Injections Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Recombinant FSH Injections Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Recombinant FSH Injections Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Recombinant FSH Injections Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Recombinant FSH Injections Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Recombinant FSH Injections Consumption Value Market Share by Region (2019-2030)
Figure 52. China Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Recombinant FSH Injections Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Recombinant FSH Injections Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Recombinant FSH Injections Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Recombinant FSH Injections Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Recombinant FSH Injections Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Recombinant FSH Injections Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Recombinant FSH Injections Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Recombinant FSH Injections Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Recombinant FSH Injections Market Drivers
Figure 73. Recombinant FSH Injections Market Restraints
Figure 74. Recombinant FSH Injections Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Recombinant FSH Injections in 2023
Figure 77. Manufacturing Process Analysis of Recombinant FSH Injections
Figure 78. Recombinant FSH Injections Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Table 1. Global Recombinant FSH Injections Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Recombinant FSH Injections Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Gonal-F (Merck) Basic Information, Manufacturing Base and Competitors
Table 4. Gonal-F (Merck) Major Business
Table 5. Gonal-F (Merck) Recombinant FSH Injections Product and Services
Table 6. Gonal-F (Merck) Recombinant FSH Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Gonal-F (Merck) Recent Developments/Updates
Table 8. Follistim (Organon) Basic Information, Manufacturing Base and Competitors
Table 9. Follistim (Organon) Major Business
Table 10. Follistim (Organon) Recombinant FSH Injections Product and Services
Table 11. Follistim (Organon) Recombinant FSH Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Follistim (Organon) Recent Developments/Updates
Table 13. Bravelle (Ferring) Basic Information, Manufacturing Base and Competitors
Table 14. Bravelle (Ferring) Major Business
Table 15. Bravelle (Ferring) Recombinant FSH Injections Product and Services
Table 16. Bravelle (Ferring) Recombinant FSH Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Bravelle (Ferring) Recent Developments/Updates
Table 18. Menopur (Ferring) Basic Information, Manufacturing Base and Competitors
Table 19. Menopur (Ferring) Major Business
Table 20. Menopur (Ferring) Recombinant FSH Injections Product and Services
Table 21. Menopur (Ferring) Recombinant FSH Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Menopur (Ferring) Recent Developments/Updates
Table 23. Fostimon (IBSA) Basic Information, Manufacturing Base and Competitors
Table 24. Fostimon (IBSA) Major Business
Table 25. Fostimon (IBSA) Recombinant FSH Injections Product and Services
Table 26. Fostimon (IBSA) Recombinant FSH Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Fostimon (IBSA) Recent Developments/Updates
Table 28. Puregon (Organon) Basic Information, Manufacturing Base and Competitors
Table 29. Puregon (Organon) Major Business
Table 30. Puregon (Organon) Recombinant FSH Injections Product and Services
Table 31. Puregon (Organon) Recombinant FSH Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Puregon (Organon) Recent Developments/Updates
Table 33. BEMFOLA (Gedeon Richter) Basic Information, Manufacturing Base and Competitors
Table 34. BEMFOLA (Gedeon Richter) Major Business
Table 35. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product and Services
Table 36. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. BEMFOLA (Gedeon Richter) Recent Developments/Updates
Table 38. Follitrope (LG Chem) Basic Information, Manufacturing Base and Competitors
Table 39. Follitrope (LG Chem) Major Business
Table 40. Follitrope (LG Chem) Recombinant FSH Injections Product and Services
Table 41. Follitrope (LG Chem) Recombinant FSH Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Follitrope (LG Chem) Recent Developments/Updates
Table 43. GenSci Basic Information, Manufacturing Base and Competitors
Table 44. GenSci Major Business
Table 45. GenSci Recombinant FSH Injections Product and Services
Table 46. GenSci Recombinant FSH Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. GenSci Recent Developments/Updates
Table 48. Global Recombinant FSH Injections Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 49. Global Recombinant FSH Injections Revenue by Manufacturer (2019-2024) & (USD Million)
Table 50. Global Recombinant FSH Injections Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 51. Market Position of Manufacturers in Recombinant FSH Injections, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 52. Head Office and Recombinant FSH Injections Production Site of Key Manufacturer
Table 53. Recombinant FSH Injections Market: Company Product Type Footprint
Table 54. Recombinant FSH Injections Market: Company Product Application Footprint
Table 55. Recombinant FSH Injections New Market Entrants and Barriers to Market Entry
Table 56. Recombinant FSH Injections Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Recombinant FSH Injections Sales Quantity by Region (2019-2024) & (K Units)
Table 58. Global Recombinant FSH Injections Sales Quantity by Region (2025-2030) & (K Units)
Table 59. Global Recombinant FSH Injections Consumption Value by Region (2019-2024) & (USD Million)
Table 60. Global Recombinant FSH Injections Consumption Value by Region (2025-2030) & (USD Million)
Table 61. Global Recombinant FSH Injections Average Price by Region (2019-2024) & (US$/Unit)
Table 62. Global Recombinant FSH Injections Average Price by Region (2025-2030) & (US$/Unit)
Table 63. Global Recombinant FSH Injections Sales Quantity by Type (2019-2024) & (K Units)
Table 64. Global Recombinant FSH Injections Sales Quantity by Type (2025-2030) & (K Units)
Table 65. Global Recombinant FSH Injections Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Global Recombinant FSH Injections Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Global Recombinant FSH Injections Average Price by Type (2019-2024) & (US$/Unit)
Table 68. Global Recombinant FSH Injections Average Price by Type (2025-2030) & (US$/Unit)
Table 69. Global Recombinant FSH Injections Sales Quantity by Application (2019-2024) & (K Units)
Table 70. Global Recombinant FSH Injections Sales Quantity by Application (2025-2030) & (K Units)
Table 71. Global Recombinant FSH Injections Consumption Value by Application (2019-2024) & (USD Million)
Table 72. Global Recombinant FSH Injections Consumption Value by Application (2025-2030) & (USD Million)
Table 73. Global Recombinant FSH Injections Average Price by Application (2019-2024) & (US$/Unit)
Table 74. Global Recombinant FSH Injections Average Price by Application (2025-2030) & (US$/Unit)
Table 75. North America Recombinant FSH Injections Sales Quantity by Type (2019-2024) & (K Units)
Table 76. North America Recombinant FSH Injections Sales Quantity by Type (2025-2030) & (K Units)
Table 77. North America Recombinant FSH Injections Sales Quantity by Application (2019-2024) & (K Units)
Table 78. North America Recombinant FSH Injections Sales Quantity by Application (2025-2030) & (K Units)
Table 79. North America Recombinant FSH Injections Sales Quantity by Country (2019-2024) & (K Units)
Table 80. North America Recombinant FSH Injections Sales Quantity by Country (2025-2030) & (K Units)
Table 81. North America Recombinant FSH Injections Consumption Value by Country (2019-2024) & (USD Million)
Table 82. North America Recombinant FSH Injections Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Europe Recombinant FSH Injections Sales Quantity by Type (2019-2024) & (K Units)
Table 84. Europe Recombinant FSH Injections Sales Quantity by Type (2025-2030) & (K Units)
Table 85. Europe Recombinant FSH Injections Sales Quantity by Application (2019-2024) & (K Units)
Table 86. Europe Recombinant FSH Injections Sales Quantity by Application (2025-2030) & (K Units)
Table 87. Europe Recombinant FSH Injections Sales Quantity by Country (2019-2024) & (K Units)
Table 88. Europe Recombinant FSH Injections Sales Quantity by Country (2025-2030) & (K Units)
Table 89. Europe Recombinant FSH Injections Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Recombinant FSH Injections Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Recombinant FSH Injections Sales Quantity by Type (2019-2024) & (K Units)
Table 92. Asia-Pacific Recombinant FSH Injections Sales Quantity by Type (2025-2030) & (K Units)
Table 93. Asia-Pacific Recombinant FSH Injections Sales Quantity by Application (2019-2024) & (K Units)
Table 94. Asia-Pacific Recombinant FSH Injections Sales Quantity by Application (2025-2030) & (K Units)
Table 95. Asia-Pacific Recombinant FSH Injections Sales Quantity by Region (2019-2024) & (K Units)
Table 96. Asia-Pacific Recombinant FSH Injections Sales Quantity by Region (2025-2030) & (K Units)
Table 97. Asia-Pacific Recombinant FSH Injections Consumption Value by Region (2019-2024) & (USD Million)
Table 98. Asia-Pacific Recombinant FSH Injections Consumption Value by Region (2025-2030) & (USD Million)
Table 99. South America Recombinant FSH Injections Sales Quantity by Type (2019-2024) & (K Units)
Table 100. South America Recombinant FSH Injections Sales Quantity by Type (2025-2030) & (K Units)
Table 101. South America Recombinant FSH Injections Sales Quantity by Application (2019-2024) & (K Units)
Table 102. South America Recombinant FSH Injections Sales Quantity by Application (2025-2030) & (K Units)
Table 103. South America Recombinant FSH Injections Sales Quantity by Country (2019-2024) & (K Units)
Table 104. South America Recombinant FSH Injections Sales Quantity by Country (2025-2030) & (K Units)
Table 105. South America Recombinant FSH Injections Consumption Value by Country (2019-2024) & (USD Million)
Table 106. South America Recombinant FSH Injections Consumption Value by Country (2025-2030) & (USD Million)
Table 107. Middle East & Africa Recombinant FSH Injections Sales Quantity by Type (2019-2024) & (K Units)
Table 108. Middle East & Africa Recombinant FSH Injections Sales Quantity by Type (2025-2030) & (K Units)
Table 109. Middle East & Africa Recombinant FSH Injections Sales Quantity by Application (2019-2024) & (K Units)
Table 110. Middle East & Africa Recombinant FSH Injections Sales Quantity by Application (2025-2030) & (K Units)
Table 111. Middle East & Africa Recombinant FSH Injections Sales Quantity by Region (2019-2024) & (K Units)
Table 112. Middle East & Africa Recombinant FSH Injections Sales Quantity by Region (2025-2030) & (K Units)
Table 113. Middle East & Africa Recombinant FSH Injections Consumption Value by Region (2019-2024) & (USD Million)
Table 114. Middle East & Africa Recombinant FSH Injections Consumption Value by Region (2025-2030) & (USD Million)
Table 115. Recombinant FSH Injections Raw Material
Table 116. Key Manufacturers of Recombinant FSH Injections Raw Materials
Table 117. Recombinant FSH Injections Typical Distributors
Table 118. Recombinant FSH Injections Typical Customers
LIST OF FIGURE
s
Figure 1. Recombinant FSH Injections Picture
Figure 2. Global Recombinant FSH Injections Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Recombinant FSH Injections Consumption Value Market Share by Type in 2023
Figure 4. Powder Examples
Figure 5. Liquid Examples
Figure 6. Global Recombinant FSH Injections Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Recombinant FSH Injections Consumption Value Market Share by Application in 2023
Figure 8. IVF and Embryo Transfer Examples
Figure 9. Infertility Treatment Examples
Figure 10. Global Recombinant FSH Injections Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Recombinant FSH Injections Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Recombinant FSH Injections Sales Quantity (2019-2030) & (K Units)
Figure 13. Global Recombinant FSH Injections Average Price (2019-2030) & (US$/Unit)
Figure 14. Global Recombinant FSH Injections Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Recombinant FSH Injections Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Recombinant FSH Injections by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Recombinant FSH Injections Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Recombinant FSH Injections Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Recombinant FSH Injections Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Recombinant FSH Injections Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Recombinant FSH Injections Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Recombinant FSH Injections Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Recombinant FSH Injections Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Recombinant FSH Injections Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Recombinant FSH Injections Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Recombinant FSH Injections Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Recombinant FSH Injections Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Recombinant FSH Injections Average Price by Type (2019-2030) & (US$/Unit)
Figure 29. Global Recombinant FSH Injections Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Recombinant FSH Injections Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Recombinant FSH Injections Average Price by Application (2019-2030) & (US$/Unit)
Figure 32. North America Recombinant FSH Injections Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Recombinant FSH Injections Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Recombinant FSH Injections Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Recombinant FSH Injections Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Recombinant FSH Injections Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Recombinant FSH Injections Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Recombinant FSH Injections Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Recombinant FSH Injections Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Recombinant FSH Injections Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Recombinant FSH Injections Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Recombinant FSH Injections Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Recombinant FSH Injections Consumption Value Market Share by Region (2019-2030)
Figure 52. China Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Recombinant FSH Injections Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Recombinant FSH Injections Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Recombinant FSH Injections Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Recombinant FSH Injections Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Recombinant FSH Injections Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Recombinant FSH Injections Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Recombinant FSH Injections Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Recombinant FSH Injections Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Recombinant FSH Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Recombinant FSH Injections Market Drivers
Figure 73. Recombinant FSH Injections Market Restraints
Figure 74. Recombinant FSH Injections Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Recombinant FSH Injections in 2023
Figure 77. Manufacturing Process Analysis of Recombinant FSH Injections
Figure 78. Recombinant FSH Injections Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
